Schaeffer Orlov S Nicole 4
4 · INSMED Inc · Filed Sep 15, 2025
Insider Transaction Report
Form 4
INSMED IncINSM
Schaeffer Orlov S Nicole
Chief People Strategy Officer
Transactions
- Sale
Common Stock
2025-09-12$144.60/sh−32,091$4,640,359→ 80,890 total - Exercise/Conversion
Stock Option (right to buy)
2025-09-12−56,520→ 0 totalExercise: $23.75Exp: 2030-01-03→ Common Stock (56,520 underlying) - Exercise/Conversion
Common Stock
2025-09-12$23.75/sh+56,520$1,342,350→ 112,981 total - Sale
Common Stock
2025-09-12$145.67/sh−30,967$4,510,963→ 49,923 total - Sale
Common Stock
2025-09-12$147.46/sh−6,158$908,059→ 36,461 total - Sale
Common Stock
2025-09-12$146.57/sh−7,304$1,070,547→ 42,619 total
Footnotes (6)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]This is the weighted average sales price representing 32,091 shares sold at prices ranging from $144.06 to $145.05 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F3]This is the weighted average sales price representing 30,967 shares sold at prices ranging from $145.06 to $146.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F4]This is the weighted average sales price representing 7,304 shares sold at prices ranging from $146.08 to $147.06 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F5]This is the weighted average sales price representing 6,158 shares sold at prices ranging from $147.12 to $148.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F6]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.